Global Landscape of Benefit–Risk Considerations for Medicinal Products: Current State and Future Directions Max WaschbuschLisa RodriguezShuai S. Yuan Current Opinion 03 July 2022 Pages: 201 - 213
A Structured Methodology to Assess Safety Signal Strength and Inform Causality Assessment Tim SullivanMagnus NordRichard P. Hermann Current Opinion Open access 04 July 2022 Pages: 215 - 222
Evaluation of the Performance of the Gulf Cooperation Council Centralised Regulatory Review Process: Strategies to Improve Product Authorisation Efficiency and Quality Hajed M. HashanSarah K. Al-MutebStuart R. Walker Original Research Article Open access 29 June 2022 Pages: 223 - 231
An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach Clare LaveryJoanne EmmottLouise Woodward Original Research Article Open access 20 June 2022 Pages: 233 - 245
Potential Channeling Bias in the Evaluation of Cardiovascular Risk: The Importance of Comparator Selection in Observational Research Hu LiFrancis MawandaStephen Motsko Original Research Article Open access 04 July 2022 Pages: 247 - 259
Major Pharmaceutical Conferences and Courses: October to November 2022 Update 15 July 2022 Pages: 261 - 264